453 related articles for article (PubMed ID: 10827174)
21. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro.
Hughes CE; Caterson B; Fosang AJ; Roughley PJ; Mort JS
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):799-804. PubMed ID: 7531436
[TBL] [Abstract][Full Text] [Related]
22. Variations in aggrecan structure modulate its susceptibility to aggrecanases.
Roughley PJ; Barnett J; Zuo F; Mort JS
Biochem J; 2003 Oct; 375(Pt 1):183-9. PubMed ID: 12859252
[TBL] [Abstract][Full Text] [Related]
23. Age-related changes in aggrecan glycosylation affect cleavage by aggrecanase.
Pratta MA; Tortorella MD; Arner EC
J Biol Chem; 2000 Dec; 275(50):39096-102. PubMed ID: 10991945
[TBL] [Abstract][Full Text] [Related]
24. Cleavage of native cartilage aggrecan by neutrophil collagenase (MMP-8) is distinct from endogenous cleavage by aggrecanase.
Arner EC; Decicco CP; Cherney R; Tortorella MD
J Biol Chem; 1997 Apr; 272(14):9294-9. PubMed ID: 9083065
[TBL] [Abstract][Full Text] [Related]
25. Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.
Patwari P; Gao G; Lee JH; Grodzinsky AJ; Sandy JD
Osteoarthritis Cartilage; 2005 Apr; 13(4):269-77. PubMed ID: 15780640
[TBL] [Abstract][Full Text] [Related]
26. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan.
Kuno K; Okada Y; Kawashima H; Nakamura H; Miyasaka M; Ohno H; Matsushima K
FEBS Lett; 2000 Aug; 478(3):241-5. PubMed ID: 10930576
[TBL] [Abstract][Full Text] [Related]
27. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.
Stanton H; Rogerson FM; East CJ; Golub SB; Lawlor KE; Meeker CT; Little CB; Last K; Farmer PJ; Campbell IK; Fourie AM; Fosang AJ
Nature; 2005 Mar; 434(7033):648-52. PubMed ID: 15800625
[TBL] [Abstract][Full Text] [Related]
28. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase.
Arner EC; Hughes CE; Decicco CP; Caterson B; Tortorella MD
Osteoarthritis Cartilage; 1998 May; 6(3):214-28. PubMed ID: 9682788
[TBL] [Abstract][Full Text] [Related]
29. Identification of an ADAMTS-4 cleavage motif using phage display leads to the development of fluorogenic peptide substrates and reveals matrilin-3 as a novel substrate.
Hills R; Mazzarella R; Fok K; Liu M; Nemirovskiy O; Leone J; Zack MD; Arner EC; Viswanathan M; Abujoub A; Muruganandam A; Sexton DJ; Bassill GJ; Sato AK; Malfait AM; Tortorella MD
J Biol Chem; 2007 Apr; 282(15):11101-9. PubMed ID: 17311924
[TBL] [Abstract][Full Text] [Related]
30. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
31. Expression and activity of ADAMTS-5 in synovium.
Vankemmelbeke MN; Holen I; Wilson AG; Ilic MZ; Handley CJ; Kelner GS; Clark M; Liu C; Maki RA; Burnett D; Buttle DJ
Eur J Biochem; 2001 Mar; 268(5):1259-68. PubMed ID: 11231277
[TBL] [Abstract][Full Text] [Related]
32. Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain.
Lark MW; Gordy JT; Weidner JR; Ayala J; Kimura JH; Williams HR; Mumford RA; Flannery CR; Carlson SS; Iwata M
J Biol Chem; 1995 Feb; 270(6):2550-6. PubMed ID: 7852317
[TBL] [Abstract][Full Text] [Related]
33. Evidence of a novel aggrecan-degrading activity in cartilage: Studies of mice deficient in both ADAMTS-4 and ADAMTS-5.
Rogerson FM; Stanton H; East CJ; Golub SB; Tutolo L; Farmer PJ; Fosang AJ
Arthritis Rheum; 2008 Jun; 58(6):1664-73. PubMed ID: 18512787
[TBL] [Abstract][Full Text] [Related]
34. "Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay.
Buttle DJ; Fowles A; Ilic MZ; Handley CJ
Mol Pathol; 1997 Jun; 50(3):153-9. PubMed ID: 9292151
[TBL] [Abstract][Full Text] [Related]
35. Characterization of an ADAMTS-5-mediated cleavage site in aggrecan in OSM-stimulated bovine cartilage.
Durigova M; Soucy P; Fushimi K; Nagase H; Mort JS; Roughley PJ
Osteoarthritis Cartilage; 2008 Oct; 16(10):1245-52. PubMed ID: 18372197
[TBL] [Abstract][Full Text] [Related]
36. Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments.
Pratta MA; Su JL; Leesnitzer MA; Struglics A; Larsson S; Lohmander LS; Kumar S
Osteoarthritis Cartilage; 2006 Jul; 14(7):702-13. PubMed ID: 16549371
[TBL] [Abstract][Full Text] [Related]
37. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.
Büttner FH; Hughes CE; Margerie D; Lichte A; Tschesche H; Caterson B; Bartnik E
Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):159-65. PubMed ID: 9639575
[TBL] [Abstract][Full Text] [Related]
38. ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein.
Westling J; Gottschall PE; Thompson VP; Cockburn A; Perides G; Zimmermann DR; Sandy JD
Biochem J; 2004 Feb; 377(Pt 3):787-95. PubMed ID: 14561220
[TBL] [Abstract][Full Text] [Related]
39. Aggrecanase and aggrecan degradation in osteoarthritis: a review.
Huang K; Wu LD
J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423
[TBL] [Abstract][Full Text] [Related]
40. ADAMTS-5 deficiency does not block aggrecanolysis at preferred cleavage sites in the chondroitin sulfate-rich region of aggrecan.
East CJ; Stanton H; Golub SB; Rogerson FM; Fosang AJ
J Biol Chem; 2007 Mar; 282(12):8632-40. PubMed ID: 17255106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
